All In Biotech

Drug Trial Radar · NCT00404547

Asthma Care With Alvesco® (Ciclesonide) in Primary Care in Adults - The ACCEPT-study (BY9010/CA-102)

An Open-Label Randomized, Multicenter Study in Patients With Asthma to Evaluate the Effectiveness of Alvesco® (Ciclesonide) Compared to Asthma Usual Care in a Primary Practice Setting

Last checked: Nov 19, 2026Latest source record: Feb 1, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 1,121 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,121

Actual

Start

Nov 2006

Primary completion

Apr 2008

Study completion Dec 2008

Sponsor

Lead sponsor
AstraZenecaAstraZeneca (AZN)
Sponsor type
Industry
First posted
Nov 28, 2006

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to investigate the effectiveness of Alvesco® (Ciclesonide) compared with usual asthma care in the primary care setting. Patients with a history of asthma for at least 6 months and who, in the opinion of the physician, meet the clinical requirements for treatment with inhaled steroids (ICS) will be enrolled. They will either receive Alvesco® or usual care.

Conditions

  • Asthma

Interventions

  • CiclesonideDrug

    Asthma Care with Alvesco

  • Usual Care Inhaled GlucocorticosteroidsDrug

    Usual asthma care and dosage as chosen by the Primary Care Physician including inhaled steroid treatment

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in Mean of Total Score of Asthma Control Questionnaire (ACQ)Time frame: At the middle and end of the 12 week treatment period

Locations

186 sites in 1 country. Site status is shown where the registry gives one.

  • "Altana Pharma/Nycomed"

    Abbotsford British Columbia, Canada

  • "Altana Pharma/Nycomed"

    Ajax, Canada

  • "Altana Pharma/Nycomed"

    Alma, Canada

  • "Altana Pharma/Nycomed"

    Anjou, Canada

  • "Altana Pharma/Nycomed"

    Anjou, Canada

  • "Altana Pharma/Nycomed"

    Barrie, Canada

  • "Altana Pharma/Nycomed"

    Brampton, Canada

  • "Altana Pharma/Nycomed"

    Brampton, Canada

  • "Altana Pharma/Nycomed"

    Brampton, Canada

  • "Altana Pharma/Nycomed"

    Brampton, Canada

  • "Altana Pharma/Nycomed"

    Brampton, Canada

  • "Altana Pharma/Nycomed"

    Brossard, Canada

  • "Altana Pharma/Nycomed"

    Burnaby, Canada

  • "Altana Pharma/Nycomed"

    Burnaby, Canada

  • "Altana Pharma/Nycomed"

    Cacouna, Canada

  • "Altana Pharma/Nycomed"

    Calgary, Canada

  • "Altana Pharma/Nycomed"

    Calgary, Canada

  • "Altana Pharma/Nycomed"

    Calgary, Canada

  • "Altana Pharma/Nycomed"

    Calgary, Canada

  • "Altana Pharma/Nycomed"

    Calgary, Canada

  • "Altana Pharma/Nycomed"

    Calgary, Canada

  • "Altana Pharma/Nycomed"

    Calgary, Canada

  • "Altana Pharma/Nycomed"

    Calgary, Canada

  • "Altana Pharma/Nycomed"

    Cambridge, Canada

  • "Altana Pharma/Nycomed"

    Collingwood, Canada

  • "Altana Pharma/Nycomed"

    Conception Bay S, Canada

  • "Altana Pharma/Nycomed"

    Cornwall, Canada

  • "Altana Pharma/Nycomed"

    Corunna, Canada

  • "Altana Pharma/Nycomed"

    Courcelette, Canada

  • "Altana Pharma/Nycomed"

    Delta, Canada

  • "Altana Pharma/Nycomed"

    Delta, Canada

  • "Altana Pharma/Nycomed"

    Dolbeau-Mistassini, Canada

  • "Altana Pharma/Nycomed"

    Edmonton, Canada

  • "Altana Pharma/Nycomed"

    Etobicoke, Canada

  • "Altana Pharma/Nycomed"

    Fort Erie, Canada

  • "Altana Pharma/Nycomed"

    Gatineau, Canada

  • "Altana Pharma/Nycomed"

    Gatineau, Canada

  • "Altana Pharma/Nycomed"

    Gatineau, Canada

  • "Altana Pharma/Nycomed"

    Gatineau, Canada

  • "Altana Pharma/Nycomed"

    Gatineau, Canada

Showing 40 of 186 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.